These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24737037)

  • 1. [DSM-5: important changes in the field of addictive diseases].
    Heinz A; Friedel E
    Nervenarzt; 2014 May; 85(5):571-7. PubMed ID: 24737037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new DSM 5 classification system: essential amendments in the psychiatric classification].
    Bauer M; Maier W; Schneider F; Kapfhammer HP
    Nervenarzt; 2014 May; 85(5):531-2. PubMed ID: 24740352
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bipolar disorders in DSM-5].
    Severus E; Bauer M
    Nervenarzt; 2014 May; 85(5):543-7. PubMed ID: 24796943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anxiety disorders in DSM-5: an overview on changes in structure and content].
    Wittchen HU; Heinig I; Beesdo-Baum K
    Nervenarzt; 2014 May; 85(5):548-52. PubMed ID: 24737036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trauma and stressor-related disorders: diagnostic conceptualization in DSM-5].
    Kapfhammer HP
    Nervenarzt; 2014 May; 85(5):553-63. PubMed ID: 24728766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substance-related and addictive disorders in the DSM-5].
    Thomasius R; Sack PM; Strittmatter E; Kaess M
    Z Kinder Jugendpsychiatr Psychother; 2014 Mar; 42(2):115-20. PubMed ID: 24571817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Addictive behaviours from DSM-IV to DSM-5].
    van den Brink W
    Tijdschr Psychiatr; 2014; 56(3):206-10. PubMed ID: 24643833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed changes in DSM-III substance use disorders: description and rationale.
    Rounsaville BJ; Spitzer RL; Williams JB
    Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurocognitive disorders in DSM-5: pervasive changes in the diagnostics of dementia].
    Maier W; Barnikol UB
    Nervenarzt; 2014 May; 85(5):564-70. PubMed ID: 24744097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mild neurocognitive disorder - a disease? For].
    Jessen F
    Nervenarzt; 2014 May; 85(5):630-1. PubMed ID: 24777656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mild neurocognitive disorder - a disease? Against].
    Frölich L
    Nervenarzt; 2014 May; 85(5):632-4. PubMed ID: 24763811
    [No Abstract]   [Full Text] [Related]  

  • 12. [DSM-5--what has changed in therapy for and research on substance-related and addictive disorders?].
    Baumgärtner G; Soyka M
    Fortschr Neurol Psychiatr; 2013 Nov; 81(11):648-54. PubMed ID: 24194058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia and other psychotic disorders in DSM-5: summary of the changes compared to DSM-IV].
    Paulzen M; Schneider F
    Nervenarzt; 2014 May; 85(5):533-42. PubMed ID: 24740353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSM-5 criteria for substance use disorders: recommendations and rationale.
    Hasin DS; O'Brien CP; Auriacombe M; Borges G; Bucholz K; Budney A; Compton WM; Crowley T; Ling W; Petry NM; Schuckit M; Grant BF
    Am J Psychiatry; 2013 Aug; 170(8):834-51. PubMed ID: 23903334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-5 and substance use disorders: clinicolegal implications.
    Norko MA; Fitch WL
    J Am Acad Psychiatry Law; 2014; 42(4):443-52. PubMed ID: 25492070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field trial of DSM-III-R psychoactive substance dependence disorders.
    Rounsaville BJ; Kosten TR; Williams JB; Spitzer RL
    Am J Psychiatry; 1987 Mar; 144(3):351-5. PubMed ID: 3826436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders.
    Nicholson R; Mackenzie C; Afifi TO; Keough M; Sareen J
    J Gambl Stud; 2019 Sep; 35(3):829-847. PubMed ID: 30778813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Considering Clinical Utility in the Construction of a Diagnostic Manual.
    Mullins-Sweatt SN; Lengel GJ; DeShong HL
    Annu Rev Clin Psychol; 2016; 12():133-55. PubMed ID: 26666967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Please, Not "Addiction" in DSM-V.
    Erickson CK; Wilcox RE
    Am J Psychiatry; 2006 Nov; 163(11):2015-6; author reply 2016-7. PubMed ID: 17074959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.